Carr Douglas, SVP of Finance and Operations at Century Therapeutics ($IPSC), sold shares on the open market eight times over the past year for a total of $5,025. His most recent sale occurred on March 9, 2026. These transactions rank 11,401st among 11,678 insiders in our database, well below the average sale value of $8.6 million and 6.4 transactions per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 7043 | $2.55 | 507,261.0000 | 86,556,515 | 1.37% | 0.01% |
| March 9, 2026 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 247 | $2.54 | 514,304.0000 | 86,464,066 | 0.05% | 0.00% |
| Feb. 3, 2026 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 323 | $1.82 | 514,551.0000 | 86,464,066 | 0.06% | 0.00% |
| Feb. 2, 2026 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 86,464,066 | 9999.99% | 0.26% |
| Feb. 2, 2026 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Common Stock | 110000 | $0.00 | 514,874.0000 | 86,464,066 | 27.17% | 0.13% |
| Dec. 8, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 257 | $0.53 | 404,874.0000 | 86,464,066 | 0.06% | 0.00% |
| Nov. 3, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 292 | $0.59 | 405,131.0000 | 86,464,066 | 0.07% | 0.00% |
| Sept. 8, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 263 | $0.50 | 405,423.0000 | 86,238,084 | 0.06% | 0.00% |
| Aug. 4, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 296 | $0.53 | 405,686.0000 | 86,238,084 | 0.07% | 0.00% |
| June 9, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 4904 | $0.62 | 405,982.0000 | 86,098,619 | 1.19% | 0.01% |
| May 5, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 295 | $0.55 | 410,886.0000 | 86,098,619 | 0.07% | 0.00% |
| March 10, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 1240 | $0.62 | 315,556.0000 | 78,648,958 | 0.39% | 0.00% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Common Stock | 95625 | $0.00 | 411,181.0000 | 78,648,958 | 30.30% | 0.12% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 95625 | $0.00 | 95,625.0000 | 78,648,958 | 9999.99% | 0.12% |
| Feb. 3, 2025 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 351 | $0.78 | 316,796.0000 | 78,648,958 | 0.11% | 0.00% |
| Nov. 4, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 283 | $1.23 | 317,147.0000 | 84,704,352 | 0.09% | 0.00% |
| Nov. 1, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | F | Common Stock | 16611 | $1.26 | 317,430.0000 | 84,704,352 | 4.97% | 0.02% |
| Aug. 5, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 289 | $1.83 | 334,041.0000 | 82,092,167 | 0.09% | 0.00% |
| June 7, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Common Stock | 17007 | $0.00 | 334,330.0000 | 62,296,637 | 5.36% | 0.03% |
| May 3, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 257 | $3.11 | 317,323.0000 | 62,296,637 | 0.08% | 0.00% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 81000 | $0.00 | 81,000.0000 | 59,314,389 | 9999.99% | 0.14% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | A | Common Stock | 14000 | $0.00 | 317,580.0000 | 59,314,389 | 4.61% | 0.02% |
| Feb. 5, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 643 | $3.84 | 304,137.0000 | 59,314,389 | 0.21% | 0.00% |
| Feb. 6, 2024 | Century Therapeutics, Inc. | $IPSC | Carr Douglas | SVP Finance & Operations | S | Common Stock | 557 | $4.49 | 303,580.0000 | 59,314,389 | 0.18% | 0.00% |